Pediatrix Medical Group Files 8-K
Ticker: MD · Form: 8-K · Filed: May 30, 2024 · CIK: 893949
Sentiment: neutral
Topics: 8-K, SEC Filing, Regulation FD
TL;DR
Pediatrix filed a standard 8-K, no major news.
AI Summary
Pediatrix Medical Group, Inc. filed an 8-K on May 30, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Pediatrix Medical Group, Inc. to the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events or financial information that would inherently increase risk.
Key Players & Entities
- Pediatrix Medical Group, Inc. (company) — Registrant
- MEDNAX, INC. (company) — Former company name
- PEDIATRIX MEDICAL GROUP INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as required by the SEC.
What is the exact name of the company filing this report?
The exact name of the company is Pediatrix Medical Group, Inc.
On what date was this report filed?
This report was filed on May 30, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 1301 Concord Terrace, Sunrise, Florida, 33323.
Has the company undergone any previous name changes?
Yes, the company was formerly known as MEDNAX, INC. (name change effective January 2, 2009) and PEDIATRIX MEDICAL GROUP INC (name change effective August 1, 1995).
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-05-30 06:50:13
Filing Documents
- md-20240530.htm (8-K) — 37KB
- md-ex99_1.htm (EX-99.1) — 5KB
- md-ex99_1s1.jpg (GRAPHIC) — 241KB
- md-ex99_1s2.jpg (GRAPHIC) — 486KB
- md-ex99_1s3.jpg (GRAPHIC) — 243KB
- md-ex99_1s4.jpg (GRAPHIC) — 826KB
- 0000950170-24-066242.txt ( ) — 2626KB
- md-20240530.xsd (EX-101.SCH) — 23KB
- md-20240530_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Pediatrix Medical Group, Inc., a Florida corporation (the "Company"), is furnishing as Exhibit 99.1 to this Current Report on Form 8-K and is incorporating herein by reference an investor presentation (the "Investor Presentation"), which may be used, in whole or in part, and subject to modification, at meetings with investors or analysts. The Investor Presentation speaks as of the date of this Current Report on Form 8-K. While the Company may elect to update the Investor Presentation in the future to reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, the Company specifically disclaims any obligation to do so. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" with the Securities and Exchange Commission nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. d) Exhibits. Exhibit Index 99.1— Presentation of Pediatrix Medical Group, Inc. dated May 30, 2024. 104 — Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pediatrix Medical Group, Inc. Date: May 30, 2024 By: /s/ C. Marc Richards C. Marc Richards Chief Financial Officer